Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Skin Cancer Diagnostics Market, by Type
1.4.2 North America Skin Cancer Diagnostics Market, by Test Type
1.4.3 North America Skin Cancer Diagnostics Market, by End-use
1.4.4 North America Skin Cancer Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Skin Cancer Diagnostics Market by Type
4.1 North America Non-Melanoma Market by Country
4.2 North America Melanoma Market by Country
Chapter 5. North America Skin Cancer Diagnostics Market by Test Type
5.1 North America Skin Biopsy Market by Country
5.2 North America Imaging Tests Market by Country
5.3 North America Dermatoscopy Market by Country
5.4 North America Lymph Node Biopsy Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Skin Cancer Diagnostics Market by End-use
6.1 North America Hospital & Clinics Market by Country
6.2 North America Laboratories Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Skin Cancer Diagnostics Market by Country
7.1 US Skin Cancer Diagnostics Market
7.1.1 US Skin Cancer Diagnostics Market by Type
7.1.2 US Skin Cancer Diagnostics Market by Test Type
7.1.3 US Skin Cancer Diagnostics Market by End-use
7.2 Canada Skin Cancer Diagnostics Market
7.2.1 Canada Skin Cancer Diagnostics Market by Type
7.2.2 Canada Skin Cancer Diagnostics Market by Test Type
7.2.3 Canada Skin Cancer Diagnostics Market by End-use
7.3 Mexico Skin Cancer Diagnostics Market
7.3.1 Mexico Skin Cancer Diagnostics Market by Type
7.3.2 Mexico Skin Cancer Diagnostics Market by Test Type
7.3.3 Mexico Skin Cancer Diagnostics Market by End-use
7.4 Rest of North America Skin Cancer Diagnostics Market
7.4.1 Rest of North America Skin Cancer Diagnostics Market by Type
7.4.2 Rest of North America Skin Cancer Diagnostics Market by Test Type
7.4.3 Rest of North America Skin Cancer Diagnostics Market by End-use
Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis
Unique Offerings 